Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

Cancer, EarlyView.

Source: Cancer - October 23, 2018 Category: Cancer & Oncology Authors: Ali Bazarbachi, Ariane Boumendil, Herv é Finel, Mohamad Mohty, Luca Castagna, Didier Blaise, Karl S. Peggs, Boris Afanasyev, J.L. Diez‐Martin, Paolo Corradini, David Michonneau, Stephen Robinson, Gonzalo Gutiérrez García, Francesca Bonif Source Type: research